Same-day surgery workflows may identify GLP-1 use too late for ideal planning
An injection delivers it directly, avoiding the need for absorbtion from the stomach (see Pernicious anaemia) no guesswork, no barriers
83 The application of gut microbiome-based therapy for MASLD seems to have a long way to go
In a small secondary analysis, plasma anandamide changed differently across abstinence and continued-use groups, but the biomarker result does not establish withdrawal mechanisms or treatment targets
Retatrutide causes significant weight loss
Weight Watchers gives you access to both: Med+ members who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight , on average, in 12 months than those who did not engage in behavioral support.^ ^Based on an internal analysis of 3,325 members who requested at least 1 GLP-1 medication refill through Weight Watchers Med+ and self-reported both a starting weight and weight at week 52